Pivotal Bio Venture Partners Investment Advisor LLC Iterum Therapeutics PLC Call Options Transaction History

Pivotal Bio Venture Partners Investment Advisor LLC

$127 Million
Q3 2024

Call Options

0 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form

No transaction found.

Others Institutions Holding ITRM

# of Institutions

Shares Held

145

Call Options Held

Put Options Held

Cypress Capital Management LLC (Wy)

66
Shares

$133
0.0% of portfolio
Blue Bell Private Wealth Management, LLC

66
Shares

$133
0.0% of portfolio
Nelson, Van Denburg & Campbell Wealth Management Group, LLC Omaha, NE

13
Shares

$26
0.0% of portfolio

View Full List

About Iterum Therapeutics plc

Ticker ITRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,233,400
Market Cap $24.7M
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...

More about ITRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pivotal Bio Venture Partners Investment Advisor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pivotal Bio Venture Partners Investment Advisor LLC with notifications on news.

Account